Business Description
Genfit SA
ISIN : US3722791098
Share Class Description:
GNFT: ADRCompare
Compare
Traded in other countries / regions
GNFT.FranceGNFT.USA0QT6.UKXUP.Germany IPO Date
2019-03-27Description
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.11 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 1.03 | |||||
| Debt-to-EBITDA | N/A |
N/A
|
N/A
| |||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -1.55 | |||||
| Beneish M-Score | -0.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 206.3 | |||||
| 3-Year EBITDA Growth Rate | 41.4 | |||||
| 3-Year EPS without NRI Growth Rate | 36.3 | |||||
| 3-Year FCF Growth Rate | 22.5 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.03 | |||||
| 9-Day RSI | 64.34 | |||||
| 14-Day RSI | 59.25 | |||||
| 6-1 Month Momentum % | 13.12 | |||||
| 12-1 Month Momentum % | -13.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.94 | |||||
| Quick Ratio | 2.94 | |||||
| Cash Ratio | 2.02 | |||||
| Days Sales Outstanding | 174.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.7 | |||||
| Shareholder Yield % | 1.31 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -340.24 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 6.48 | |||||
| PS Ratio | 9.81 | |||||
| PB Ratio | 2.49 | |||||
| Price-to-Tangible-Book | 8.74 | |||||
| EV-to-Revenue | 9.74 | |||||
| EV-to-Forward-Revenue | 1.81 | |||||
| EV-to-FCF | -2.77 | |||||
| Price-to-Net-Current-Asset-Value | 23.5 | |||||
| FCF Yield % | -33.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GNFT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genfit SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 18.563 | ||
| EPS (TTM) ($) | -0.741 | ||
| Beta | 1.02 | ||
| Volatility % | 29.96 | ||
| 14-Day RSI | 59.25 | ||
| 14-Day ATR ($) | 0.148752 | ||
| 20-Day SMA ($) | 3.55522 | ||
| 12-1 Month Momentum % | -13.89 | ||
| 52-Week Range ($) | 2.8935 - 4.75 | ||
| Shares Outstanding (Mil) | 49.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genfit SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genfit SA Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genfit SA Frequently Asked Questions
What is Genfit SA(GNFT)'s stock price today?
The current price of GNFT is $3.76. The 52 week high of GNFT is $4.75 and 52 week low is $2.89.
When is next earnings date of Genfit SA(GNFT)?
The next earnings date of Genfit SA(GNFT) is 2024-07-04 Est..
Does Genfit SA(GNFT) pay dividends? If so, how much?
Genfit SA(GNFT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers